亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

武漢遠(yuǎn)城科技發(fā)展有限公司銷售八部  

肉桂酸、肉桂醛、肉桂醇、及公司經(jīng)營的生物化工、醫(yī)藥中間體等產(chǎn)品

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:劉
  • 電話:02788320827
  • 郵件:yucheng011@yuanchengdope.com
  • 傳真:02788048077
  • QQ:172616357
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
桿菌肽鋅
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
過期 長期有效
更新 2011-04-16 11:43
 
詳細(xì)信息
桿菌肽鋅 
英文名稱:Bacitracin Zinc
 CAS 編號:1405-89-6 
包裝規(guī)格:1kg/5kg/10kg/20kg
規(guī)格型號:(CPV/USP/EP) 
產(chǎn)品說明: 產(chǎn)品名稱:桿菌肽鋅
英文名: Bacitracin Zinc
執(zhí)行標(biāo)準(zhǔn):USP24 / EP4
分子式:C63H98N14O14SZn
CAS No.:1405-89-6
外觀:類白色或淡黃色粉末,有特臭。
作用:桿菌肽鋅屬多肽類抗生素,對革蘭陽性菌具有殺菌作用,其機(jī)制主要為抑制細(xì)
菌的細(xì)菌壁合成,也能與敏感細(xì)菌的細(xì)胞膜結(jié)合,損傷細(xì)胞膜的完整性,導(dǎo)致細(xì)胞內(nèi)
重要物質(zhì)外流。有效抑制革蘭氏的陽性菌和部分革蘭氏陰性菌;細(xì)菌對桿菌肽耐藥的
速度較慢,與其他抗生素之間無交叉耐藥性。促進(jìn)畜禽生長,提高飼料轉(zhuǎn)換率。桿菌
肽鋅內(nèi)服幾乎不吸收,大部分在2天內(nèi)隨糞便排出。桿菌肽鋅與青霉素、鏈霉素、新霉
素、金霉素、黏菌素等有協(xié)同抗菌作用。本品與喹乙醇、吉他霉素、維吉尼亞霉素、
恩拉霉素存在配伍禁忌。用于革蘭氏陽性菌及耐青霉素葡萄球菌的感染。
Bacitracin Zinc
 CAS No. :1405 -89-6
Packing: 1kg/5kg/10kg/20kg
Specification: (CPV / USP / EP)
Product Description: Product Name: zinc bacitracin
English name: Bacitracin Zinc
Executive standard: USP24 / EP4
Molecular formula: C63H98N14O14SZn
CAS No. :1405-89-6
Appearance: white or light yellow powder with special smell.
Role: Bacitracin Zinc is a peptide antibiotic, against gram-positive 
bacteria with a bactericidal effect, the mechanism of the inhibition 
of the bacterial cell wall synthesis of bacteria, also with sensitive
 bacterial cell membrane, damage the integrity of the cell membrane, 
leading to important material cells outflow. Inhibit Gram-positive
 bacteria and some gram-negative bacteria; bacteria resistant to 
bacitracin slower, and other non-cross-resistance between antibiotics.
©2025 武漢遠(yuǎn)城科技發(fā)展有限公司銷售八部 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:27693  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |